Cerebrospinal fluid taurine after traumatic brain injury

Neurochemical Research

Volumn 30, Issue 1, 2005, Pages 123-128

  Seki, Yukio ^a   Kimura, Masaaki ^b   Mizutani, Nobuhiko ^b   Fujita, Mitsugu ^b   Aimi, Yuri ^b   Suzuki, Yoshio ^b  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Cytotoxic edema; Regulatory volume decrease; Taurine; Traumatic brain injury

Indexed keywords

AMINO ACID; ARGININE; BRAIN PROTEIN; GLUTAMINE; PHOSPHOETHANOLAMINE; TAURINE;

ADULT; AGED; AMINO ACID BRAIN LEVEL; ARTICLE; ASTROCYTE; BRAIN INJURY; CATHETERIZATION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INTRACRANIAL PRESSURE; MALE; MEASUREMENT; MORPHOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS, NONPARAMETRIC; TAURINE; TIME FACTORS;

EID: 13844275282     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-004-9693-4     Document Type: Article

References (25)

1. Bullock, R., Maxwell, W. L., Graham, D. I., Teasdale, G. M., and Adams, J. H. 1991. Glial swelling following human cerebral contusion: an ultrastructural study. J. Neurol. Neurosurg. Psychiatry 54: 427-434.
2. Kimelberg, H. K. 1995. Current concepts of brain edema. Review of laboratory investigations. J. Neurosurg. 83: 1051-1059.
3. + medium causes inhibition of glutamate and aspartate uptake and increases their release. J. Cereb. Blood Flow Metab. 15: 409-416.
4. Schousboe, A. and Pasantes-Morales, H. 1992. Role of taurine in neural cell volume regulation. Can. J. Physiol. Pharmacol. 70: S356-S361.
5. Staub, F., Baethmann, A., Peters, J., Weigt, P. H., and Kempski, O. 1990. Effects of lactacidosis on glial cell volume and viability. J. Cereb. Blood. Flow Metab. 10: 866-876.
6. Estevez, A. Y., O'Regan, M. H., Song, D., and Phillis, J. W. 1999. Effects of anion channel blockers on hyposmotically induced amino acid release from the in vivo rat cerebral cortex. Neurochem. Res. 24: 447-452.
7. Pasantes-Morales, H., Quesada, O., and Morán, J. 1998. Taurine: an osmolyte in mammalian tissues. In Schaffer et al. (eds.), Taurine 3, Plenum Press, New York, Pages 209-217.
8. Pasantes-Morales, H. and Schousboe, A. 1989. Release of taurine from astrocytes during potassium-evoked swelling. Glia 2: 45-50.
9. Solís, J. M., Herranz, A. S., Herreras, O., Lerma, J., and Martin del Río, R. 1988. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci. Lett. 91: 53-58.
10. Lee, P. L. Y. and Slocum, R. H. 1988. A high-resolution method for amino acid analysis of physiological fluids containing mixed disulfides. Clin. Chem. 34: 719-723.
11. Jackson, P. S., Morrison, R., and Strange, K. 1994. The volume-sensitive organic osmolyte-anion channel VSOAC is regulated by nonhydrolytic ATP binding. Am. J. Physiol. 267(5 Pt1): C1203-C1209.
12. Birdsall, T. C. 1998. Therapeutic applications of taurine. Alt. Med. Rev. 3: 128-136.
13. Stapleton, P. P., O'Flaherty, L., Redmond, H. P., and Bouchier-Hayes, D. J. 1998. Host defense-a role for the amino acid taurine? JPEN. 22: 42-48.
14. Katayama, Y., Becker, D. P., Tamura, T., and Hovda, D. A. 1990. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73: 889-900.
15. McD Anderson, R. and Opeskin, K. 1998. Timing of early changes in brain trauma. Am. J. Forensic. Med. Pathol. 61: 1-9.
16. Stover, J. F., Morganti-Kossmann, M. C., Lenzlinger, P. M., Stocker, R., Kempski, O. S., and Kossmann, T. 1999. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J. Neurotrauma. 16: 135-142.
17. Rosenberg, G. A., Kyner, W. T., and Estrada, E. 1980. Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am. J. Physiol. 238: F42-F49.
18. Shimada, N., Graf, R., Rosner, G., and Heiss, W-D. 1993. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J. Neurochem.60: 66-71.
19. Hayes, K. C. 1985. Taurine requirement in primates. Nutr Rev. 43: 65-70.
20. Paauw, J. D. and Davis, A. T. 1990. Taurine concentrations in serum of critically injured patients and age- and sex-matched healthy control subjects. Am. J. Clin. Nutr. 52: 657-660.
21. McGale, E. H. F., Pye, I. F., Stonier, C., Hutchinson, E. C., and Aber, G. M. 1977. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J. Neurochem. 29: 291-297.
22. Pomara, N., Singh, R., Deptula, D., Chou, J. C-Y., Schwartz, M. B., and LeWitt, P. A. 1992. Glutamate and other CSF amino acids in Alzheimer's disease. Am. J. Psychiatry 149: 251-254.
23. 2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase-2 expression. Mol. Brain. Res. 59: 189-195.
24. Redmond, H. P., Stapleton, P. P., Neary, P., and Bouchier-Hayes, D. 1998. Immunonutrition: the role of taurine. Neutrition 14: 599-604.
25. Park, E., Alberti, J., Quinn, M. R., and Schuller-Levis, G. 1998. Taurine chloramine inhibits the production of superoxide anion, IL-6 and IL-8 in activated human polymorphonuclear leukocytes. Adv. Exp. Med. Biol. 442: 177-182.